Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohsen Rashidi

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Clinical Pharmacology|January 26, 2023
The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic reviewEhsan Motaghi, Masoumeh Ghasemi-Pirbaluti, Mohsen Rashidi, et al.
Iranian Red Crescent Medical Journal|October 6, 2016
Umbelliprenin is Potentially Toxic Against the HT29, CT26, MCF-7, 4T1, A172, and GL26 Cell Lines, Potentially Harmful Against Bone Marrow-Derived Stem Cells, and Non-Toxic Against Peripheral Blood Mononuclear CellsMohsen Rashidi, Seyed Ali Ziai, Taraneh Moini Zanjani, et al.
Chemico-Biological Interactions|August 13, 2022
Harmaline downregulates angiogenesis markers and suppresses the growth of 4T1 breast cancer cells in vivo and in vitroMohsen Rashidi, Elham Mahmoudian, Sepideh Mirzaei, et al.
Journal of Cellular Physiology|May 26, 2018
Umbelliprenin shows antitumor, antiangiogenesis, antimetastatic, anti-inflammatory, and immunostimulatory activities in 4T1 tumor-bearing Balb/c miceMohsen Rashidi, Ahad Khalilnezhad, Davar Amani, et al.
Advanced Pharmaceutical Bulletin|May 27, 2022
CRISPER/CAS System, a Novel Tool of Targeted Therapy of Drug-Resistant Lung CancerVahid Akbari Kordkheyli, Mohsen Rashidi, Yasaman Shokri, et al.
Biochemical Pharmacology|June 3, 2014
Triangular gold nanoparticles conjugated with peptide ligands: a new class of inhibitor for Candida albicans secreted aspartyl proteinaseAli Jebali, Farzaneh Haji Esmaeil Hajjar, Seyedhossein Hekmatimoghaddam, et al.
Journal of Applied Microbiology|September 5, 2023
The growth inhibitory and apoptotic effects of umbelliprenin in a mouse model of systemic candidiasisMohsen Rashidi, Ali Bazi, Alireza Ahmadzadeh, et al.
Hormone Molecular Biology and Clinical Investigation|December 1, 2021
Effect of Auraptene on angiogenesis in Xenograft model of breast cancerMohammad Reza Shiran, Elham Mahmoudian, Abolghasem Ajami, et al.
International Journal of Ophthalmology|January 19, 2024
Impact of umbelliprenin-containing niosome nanoparticles on <i>VEGF-A</i> and <i>CTGF</i> genes expression in retinal pigment epithelium cellsFarzad Dastaviz, Akram Vahidi, Teymoor Khosravi, et al.
Journal of Cellular and Molecular Medicine|August 15, 2023
Hesperidin suppressed metastasis, angiogenesis and tumour growth in Balb/c mice model of breast cancerElham Shakiba, Ali Bazi, Hamed Ghasemi, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Clinical Pharmacology|January 26, 2023
The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic reviewEhsan Motaghi, Masoumeh Ghasemi-Pirbaluti, Mohsen Rashidi, et al.
Iranian Red Crescent Medical Journal|October 6, 2016
Umbelliprenin is Potentially Toxic Against the HT29, CT26, MCF-7, 4T1, A172, and GL26 Cell Lines, Potentially Harmful Against Bone Marrow-Derived Stem Cells, and Non-Toxic Against Peripheral Blood Mononuclear CellsMohsen Rashidi, Seyed Ali Ziai, Taraneh Moini Zanjani, et al.
Chemico-Biological Interactions|August 13, 2022
Harmaline downregulates angiogenesis markers and suppresses the growth of 4T1 breast cancer cells in vivo and in vitroMohsen Rashidi, Elham Mahmoudian, Sepideh Mirzaei, et al.
Journal of Cellular Physiology|May 26, 2018
Umbelliprenin shows antitumor, antiangiogenesis, antimetastatic, anti-inflammatory, and immunostimulatory activities in 4T1 tumor-bearing Balb/c miceMohsen Rashidi, Ahad Khalilnezhad, Davar Amani, et al.
Advanced Pharmaceutical Bulletin|May 27, 2022
CRISPER/CAS System, a Novel Tool of Targeted Therapy of Drug-Resistant Lung CancerVahid Akbari Kordkheyli, Mohsen Rashidi, Yasaman Shokri, et al.
Biochemical Pharmacology|June 3, 2014
Triangular gold nanoparticles conjugated with peptide ligands: a new class of inhibitor for Candida albicans secreted aspartyl proteinaseAli Jebali, Farzaneh Haji Esmaeil Hajjar, Seyedhossein Hekmatimoghaddam, et al.
Journal of Applied Microbiology|September 5, 2023
The growth inhibitory and apoptotic effects of umbelliprenin in a mouse model of systemic candidiasisMohsen Rashidi, Ali Bazi, Alireza Ahmadzadeh, et al.
Hormone Molecular Biology and Clinical Investigation|December 1, 2021
Effect of Auraptene on angiogenesis in Xenograft model of breast cancerMohammad Reza Shiran, Elham Mahmoudian, Abolghasem Ajami, et al.
International Journal of Ophthalmology|January 19, 2024
Impact of umbelliprenin-containing niosome nanoparticles on <i>VEGF-A</i> and <i>CTGF</i> genes expression in retinal pigment epithelium cellsFarzad Dastaviz, Akram Vahidi, Teymoor Khosravi, et al.
Journal of Cellular and Molecular Medicine|August 15, 2023
Hesperidin suppressed metastasis, angiogenesis and tumour growth in Balb/c mice model of breast cancerElham Shakiba, Ali Bazi, Hamed Ghasemi, et al.
Pageof 10